An intervention that modulates weight loss and counterbalances the increased NfL could be clinically meaningful, as both of these phenomena predict a faster functional decline in people with Alzheimer’s disease (AD) and frontotemporal dementia (FTD) [10,11]. Here, NEFL is linked to Alzheimer disease.